［1］贾伟平,陆菊明.中国2型糖尿病防治指南（2017年版）编写说明［J］. 中华糖尿病杂志，2018，10（1）：2-67.
［2］刘华伟,赵勇,李贵生,等.FGF-1及其突变体的研究进展［J］.中国生物工程杂志,2005，25(8)：1-5.
［3］Fernandes-Freitas I, Owen BM. Metabolic roles of endocrine fibroblast growth factors［J］. Curr Opin Pharmacol, 2015, 25:30-35.
［4］Itoh N．Hormone-like(endocrine)FGFs：their evolutionary history and roles in development，metabolism，and disease［J］．Cell Tissue Res，2010，342(1)：1-11．
［5］Chi YH，Kumar TK，Chiu IM，et al. Identification of rare partially unfolded states in equilibrium with the native conformation in an all beta-barrel protein［J］．J Biol Chem，2002，277(38)：34941-34948．
［6］谭亚清,刘德虎.人酸性成纤维细胞生长因子的研究进展［J］.生物技术通报,2013,1(5):22-27.
［7］Hayrabedyan S，Kyurkchiev S，Kehayov I．FGF-1 and S100A13 possibly contribute to angiogenesis in endometriosis［J］．J Reprod Immunol，2005，67(1/2)：87-101．
［8］Zakrzewska M，Krowarsch D，Wiedlocha A，et a1．Structural requirements of FGF-1 for receptor binding and translocation into cells［J］．Biochemistry,2006,45(51)：15 338-15348.
［9］田利娜，曹仁贤，刘星，等．shRNA干扰S100A13基因对人甲状腺癌细胞释放成纤维细胞生长因子1的影响［J］．中华内分泌代谢杂志,2010,26(10)：847-849．
［10］Mohan SK，Rani SG，Kumar SM，et a1．S100A13-C2A binary complex structure-a key component in the acidic fibroblast growth factor for the non-classical pathway［J］．Biochem Biophys Res Commun,2009,380(3)：5l4-519．
［11］Jonker JW，Suh JM，Atkins AR，et al．A PPARγ-FGF1 axis is required for adaptive adipose remodelling and metabolic homeostasis［J］．Nature,2012,485(7398)：391-394．
［12］Suh JM, Jonker JW, Ahmadian M, et al .Endocrinization of FGF1 produces a neomorphic and potent insulin sensitizer［J］.Nature，2014，513(7518):436-439.
［13］Scarlett JM, Rojas JM, Matsen ME，et al.Central injection of fibroblast growth factor 1 induces sustained remission of diabetic hyperglycemia in rodents［J］.Nat Med, 2016,22(7):800-806.
［14］Wang S, Yang Q, Yu S, et al.Fibroblast growth factor 1 levels are elevated in newly diagnosed type 2 diabetes compared to normal glucose tolerance controls［J］. Endocr J, 2016,63(4):359-365.
［15］Hoseini SJ, Ghazavi H, Forouzanfar F,et al.Fibroblast Growth Factor 1-Transfected Adipose-Derived Mesenchymal Stem Cells Promote Angiogenic Proliferation［J］.DNA Cell Biol, 2017,36(5):1-12.
［16］Sun K, Scherer PE．The PPARγ-FGF1 axis：an unexpected mediator of adipose tissue homeostasis［J］．Cell Res,2012,22(10)：1416-1418．
［17］Liu W, Struik D, Nies VJ, et al.Effective treatment of steatosis and steatohepatitis by fibroblast growth factor 1 in mouse models of nonalcoholic fatty liver disease［J］. Proc Natl Acad Sci,2016,113(8):2288-2293.
［18］Zhao YZ, Zhang M, Wong HL, et al.Prevent diabetic cardiomyopathy in diabetic rats by combined therapy of aFGF-loaded nanoparticles and ultrasound-targeted microbubble destruction technique［J］. J Control Release,2016, 223:11-21.
［19］Zhu J, Wang Y, Zhu K，et al. Serum Fibroblast Growth Factor 1 is Associated with the Decreased Risk of Obesity in Human［J］.Exp Clin Endocrinol Diabetes, 2017,125(5):322-326.
［20］Skibba M, Zhang C, Jiang X, et al. Preventive effect of non-mitogenic acidic fibroblast growth factor on diabetes-induced testicular cell death［J］. Reprod Toxicol, 2014, 49:136-144.
［21］Li M, Page-McCaw P, Chen W. FGF1 Mediates Overnutrition-Induced Compensatory β-Cell Differentiation［J］. Diabetes, 2016,65(1):96-109.
［22］Perry RJ, Lee S, Ma L, et al.FGF1 and FGF19 reverse diabetes by suppression of the hypothalamic-pituitary-adrenal axis［J］.Nat Commun, 2015, 6(6980) :1-10.
［23］Zhang C, Zhang L, Chen S, et al.The prevention of diabetic cardiomyopathy by nonmitogenic acidic fibroblast growth factor is probably mediated by the suppression of oxidative stress and damage［J］. PLoS One, 2013, 8(12):e82287.
［24］He J, Chen DL, Samocha-Bonet D, et al. Fibroblast growth factor-1 (FGF-1) promotes adipogenesis by downregulation of carboxypeptidase A4 (CPA4)-a negative regulator of adipogenesis implicated in the modulation of local and systemic insulin sensitivity［J］. Growth Factors, 2016, 34(5/6):210-216.
［25］Gasser E, Moutos CP, Downes M, et al. FGF1 - a new weapon to control type 2 diabetes mellitus［J］. Nat Rev Endocrinol, 2017 , 13 (10) :599-609.